Luckwel Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Luckwel Pharmaceuticals generated cash of -$197, which is more than the previous year. Cash used in financing activities reached the amount of $199 last year. Net change in cash is therefore $1.
Cash Flow
| 2014 | -206 | 0 | 300 |
|---|---|---|---|
| 2015 | -244 | 0 | 198 |
| 2016 | -403 | 0 | 39 |
| 2017 | -461 | 0 | 404 |
| 2018 | -515 | 0 | 504 |
| 2019 | -622 | 0 | 629 |
| 2020 | -318 | 0 | 292 |
| 2021 | -197 | 0 | 199 |
LWEL Cash Flow Statement (2014 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 0 | 25 | 18 | 29 | 116 | 48 | 94 | -1 |
Operating activities | ||||||||
Net income | -436 | -536 | -622 | -537 | -510 | -407 | -264 | -224 |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 0 | 9 | 27 | 18 |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 6 | 70 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 6 | 70 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | -9.34K | 9.34K |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | -1.57K | -9.34K | 0 |
Cash generated by operating activities | -197 | -318 | -622 | -515 | -461 | -403 | -244 | -206 |
Investing activities | ||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financing activities | ||||||||
Common Stock Issued | 120K | 0 | 0 | 422.94K | 112.50K | 420K | 0 | 136K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -40 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | -101.66K | 0 | 0 |
Cash used in financing activities | 199 | 292 | 629 | 504 | 404 | 39 | 198 | 300 |
Net Change In Cash | 1 | -25 | 7 | -10 | -87 | 68 | -46 | 94 |
Cash at end of period | 2 | 0 | 25 | 18 | 29 | 116 | 48 | 94 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |